Prospective Data Collection Among Women Using Cold Caps During TC Chemotherapy
Study Status
Open to Enrollment
Study Description
This study includes women with early-stage breast cancer who are receiving chemotherapy with docetaxel and cyclophosphamide at the outpatient chemotherapy infusion center at the Weill Cornell Breast Center and who have chosen to use a cold cap during treatment.
Cold caps are a commercially available device designed to prevent hair loss associated with chemotherapy. The Weill Cornell Breast Center does not endorse cold caps but supports our patients who choose to use them.
The purpose of the study is to observe patients using cold caps and evaluate how well the cold caps work in preventing chemotherapy-induced hair loss using digital photographs.
We will take photographs of your head before you begin chemotherapy, at every chemotherapy visit and 3 weeks after chemotherapy is completed. We will also collect information about your medical history from your medical records. You will be followed in the study for as long as you are using cold caps while receiving chemotherapy and for approximately 3 weeks after chemotherapy is completed. On average, this could be about 3 months.
Cold caps are not provided as part of this research study.
Disease Status and/or Stage
Early-Stage Breast Cancer
Key Eligibility
- Early-stage breast cancer
- Receiving chemotherapy with docetaxel and cyclophosphamide at Weill Cornell Breast Center
- Using a cold cap during treatment
Principal Investigator
Contact
- Martarita Maxwell
- (212) 821-0644
Healthy Volunteers
As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.
Contact Us
For general inquiries, or if you need assistance finding a study, please contact:
Erica Bersin
Tel: (646) 962-8232
[email protected]
